Skip to main content

Engineering Immunity

Overview

Engineering Immunity Type: Vanderbilt Initiative Award (ViA)

From cancer to diabetes to chronic infections, our immune system plays an important role in nearly every disease. Accordingly, harnessing the power and exquisite specificity of the immune system has enormous – and still largely untapped – potential to improve human health and wellbeing. The mission of ‘Engineering Immunity’ is to integrate the fields of immunology and engineering at Vanderbilt to address challenges in tumor immunology and advance discovery and empower clinically relevant cancer interventions. This TIP integrates medicine, engineering and the basic sciences by leveraging existing trans-institutional investments in immunobiology, nanotechnology and imaging. Engineering Immunity will bring together synergistic expertise in bioengineering, advanced materials, medical imaging, and immunology to understand, modulate and visualize immunology and anti-tumor immunity in ways not previously possible. This initiative provides Vanderbilt unique capabilities in the field that will make Vanderbilt a world leader in cancer immunology to develop innovative technologies with the potential to revolutionize cancer therapy.

Faculty Participants

Principal Investigator in bold

School of Medicine (Clinical)

  • Jeffrey Rathmell, Cornelius Vanderbilt Professor of Immunobiology in Pathology, Microbiology and Immunology
  • Sebastian JoyceProfessor of Pathology, Microbiology and Immunology
  • Charles CaskeyAssistant Professor of Radiology and Radiological Sciences

School of Engineering

  • Todd Giorgio, Professor of Biomedical Engineering
  • John Wilson, Assistant Professor of Chemical and Biomolecular Engineering
  • William Grissom, Assistant Professor of Biomedical Engineering